Multi-drug combination designs with experiments in silico

被引:1
|
作者
Huang Hengzhen [1 ]
机构
[1] Guangxi Normal Univ, Coll Math & Stat, Guilin, Peoples R China
基金
中国国家自然科学基金;
关键词
Computer experiments; Dose-response surface; Optimal design; Prediction; Uniform design; SAMPLE-SIZE DETERMINATION; RESPONSE-SURFACE MODEL; COMPUTER EXPERIMENTS; DRUG-COMBINATION; REGRESSION;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has become evident to medical and statistical scientists treating complex diseases that satisfactory efficacy is more likely to be achieved by using combinations of drugs. Experimental design for drug combination in pre-clinical studies is an important stage to move new combination therapies rapidly into clinical trials. The existing design methods for pre-clinical studies are primarily applied to combination experiments with two or three combined drugs. However, as the research of systems biology advancing it is becoming more desire to consider combinations with multiple drugs. In this paper, we propose efficient experimental designs for multi-drug combination studies. The aim of the proposed design is to establish a good quality and high dimensional dose-response model which provides a basis for future developments on statistical analysis for complex multi-drug dose-finding problems. By borrowing the strength of experiments in silico, it turns out that the uniform design measure is the optimal design with respect to model prediction accuracy. Methods for sample size determination and how to construct uniform designs are given. Since the proposed uniform designs are constructed in regular dose regions, they are convenient to be applied to multi-drug combination experiments. The usefulness of the proposed design is illustrated by simulations and an application with multiple combined drugs.
引用
收藏
页码:373 / 388
页数:16
相关论文
共 50 条
  • [21] An In-Silico Investigation to Design a Multi-Epitopes Vaccine against Multi-Drug Resistant Hafnia alvei
    Alshabrmi, Fahad M.
    Alrumaihi, Faris
    Alrasheedi, Sahar Falah
    Al-Megrin, Wafa Abdullah, I
    Almatroudi, Ahmad
    Allemailem, Khaled S.
    VACCINES, 2022, 10 (07)
  • [22] Biodegradable multi-drug dispenser
    Melanie Brazil
    Nature Reviews Drug Discovery, 2003, 2 : 946 - 946
  • [23] Multi-drug resistant tuberculosis
    Selvakumar, N
    MULTI-DRUG RESISTANCE IN EMERGING AND RE-EMERGING DISEASES, 2000, : 133 - 145
  • [24] MULTI-DRUG THEOPHYLLINE OVERDOSE
    SCHWARTZ, MP
    TAYLOR, AT
    JOURNAL OF FAMILY PRACTICE, 1989, 28 (05): : 575 - 577
  • [25] Multi-drug resistant tuberculosis
    Ebrahim, GJ
    JOURNAL OF TROPICAL PEDIATRICS, 2000, 46 (06) : 320 - 321
  • [26] Multi-drug resistance and cancer
    Atalay, Can
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (05) : 511 - 520
  • [27] STATISTICAL DESIGNS FOR EXPERIMENTS IN COMBINATION THERAPY
    MILLER, I
    CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT, 1974, 4 (01): : 151 - 156
  • [28] Drug delivery - Biodegradable multi-drug dispenser
    Brazil, M
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (12) : 946 - 947
  • [29] Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
    Ziemba, Michael
    Barkhouse, Molly
    Uaesoontrachoon, Kitipong
    Giri, Mamta
    Hathout, Yetrib
    Dang, Utkarsh J.
    Gordish-Dressman, Heather
    Nagaraju, Kanneboyina
    Hoffman, Eric P.
    PLOS ONE, 2021, 16 (02):
  • [30] Successful Treatment of Adult Onset Langerhans Cell Histiocytosis with Multi-Drug Combination Therapy
    Matsuki, Eri
    Tsukada, Yuiko
    Nakaya, Aya
    Yokoyama, Kenji
    Okamoto, Shinichiro
    INTERNAL MEDICINE, 2011, 50 (08) : 909 - 914